Hallen Ed
Hallen Ed, DIR, reported an open-market or private sale at Klaviyo, Inc. involving 39167.000000 shares for an estimated $801748.49. Reported holdings after the transaction were 94457.000000 shares. The stored filing text includes a detected 10b5-1 reference.
- Trade date
- Aug 31, 2026
- Filing date
- Sep 02, 2026
How reported position traded is calculated
Shares sold ÷ (holdings after + shares sold). Estimated position before: 133,624 shares.
Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.
KVYO price since this filing
Daily closing prices, with the filing date and available return windowsTransaction facts
Stored Form 4 columns with their raw values
- Type
- Sell Code S
- Identifier
- 0001470831-26-000870 Series A Common Stock
- Transaction date
- Aug 31, 2026 Filed Sep 02, 2026, 12:18 AM · 2d delay
- Shares
- 39,167 sh $20.47 per share
- Estimated value
- -$801k Computed from shares × price
- Holdings after
- 94,457 sh Indirect · By Hodgkins Trust
Filing signal explanations
Badges describe filing facts only — not predictions.
-6 points
Compact filing score computed from stored Form 4 facts. Version v1.
This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.
How this score is calculated
- timely_filing+4 points
reporting_delay_days = 2
Filing reported within two business days of the transaction. - tenb5_1_detected-10 points
is_10b5_1 = true
Stored filing content includes detected 10b5-1 language.
Signed filing-only points, not a probability or expected return. Version v1.
Reported relationships & other filings
Form 4 relationship flags and nearby filing context
No officer title
- F1
These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 1, 2026.
- F2
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $20.30 to $20.77 per share. The Reporting Person undertakes to provide…
- F3
Shares are owned directly by Hodgkins Trust for the benefit of the Reporting Person and the Reporting Person's family, and of which the trustee is an independent institution. The Reporting Person disc…
- F4
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $20.30 to $20.78 per share. The Reporting Person undertakes to provide…
- F5
Shares held by Hodgkins LLC, of which the Reporting Person serves as manager. The Reporting Person disclaims Section 16 beneficial ownership of such shares except to the extent of his pecuniary intere…
- F6
Represents a bona fide gift of 17,885 shares of stock from Hodgkins LLC, of which Reporting Person serves as manager, to a donor-advised fund pursuant to a Rule 10b5-1 trading plan adopted by the Repo…
0 other transactions
0 recent txs